Mengxing Liu

530 total citations
18 papers, 341 citations indexed

About

Mengxing Liu is a scholar working on Biomedical Engineering, Molecular Biology and Cancer Research. According to data from OpenAlex, Mengxing Liu has authored 18 papers receiving a total of 341 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Biomedical Engineering, 6 papers in Molecular Biology and 5 papers in Cancer Research. Recurrent topics in Mengxing Liu's work include Nanoplatforms for cancer theranostics (5 papers), MicroRNA in disease regulation (4 papers) and Molecular Sensors and Ion Detection (3 papers). Mengxing Liu is often cited by papers focused on Nanoplatforms for cancer theranostics (5 papers), MicroRNA in disease regulation (4 papers) and Molecular Sensors and Ion Detection (3 papers). Mengxing Liu collaborates with scholars based in China and United States. Mengxing Liu's co-authors include Wei Guo, Hong‐Xing Zhang, Jing Liu, Ming Xian, Xuehong Wei, Jing Liu, Juanjuan Wang, Jing Liu, Yuanqiang Sun and Wei Li and has published in prestigious journals such as Journal of the American Chemical Society, Nucleic Acids Research and Angewandte Chemie International Edition.

In The Last Decade

Mengxing Liu

16 papers receiving 334 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mengxing Liu China	8	112	100	97	88	72	18	341
Jili Li China	13	192 1.7×	131 1.3×	18 0.2×	75 0.9×	72 1.0×	36	384
Qiang-Zhe Zhang China	8	119 1.1×	107 1.1×	165 1.7×	84 1.0×	200 2.8×	10	371
Eun-Sun Lee South Korea	9	187 1.7×	62 0.6×	17 0.2×	36 0.4×	30 0.4×	20	338
Lizhou Yue China	10	99 0.9×	72 0.7×	134 1.4×	82 0.9×	122 1.7×	14	305
Jonathan Cotton Germany	8	118 1.1×	78 0.8×	9 0.1×	25 0.3×	13 0.2×	22	355
Fengli Zhang China	11	205 1.8×	100 1.0×	61 0.6×	102 1.2×	12 0.2×	30	416
Yuantao Mao China	5	84 0.8×	92 0.9×	92 0.9×	106 1.2×	52 0.7×	6	287
William Wolter United States	9	168 1.5×	39 0.4×	80 0.8×	52 0.6×	10 0.1×	14	417
Yutong Wang China	12	248 2.2×	60 0.6×	46 0.5×	47 0.5×	38 0.5×	39	447
Xinjing Tang China	10	190 1.7×	37 0.4×	44 0.5×	88 1.0×	112 1.6×	20	351

Countries citing papers authored by Mengxing Liu

Since Specialization

Citations

This map shows the geographic impact of Mengxing Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mengxing Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mengxing Liu more than expected).

Fields of papers citing papers by Mengxing Liu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mengxing Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mengxing Liu. The network helps show where Mengxing Liu may publish in the future.

Co-authorship network of co-authors of Mengxing Liu

This figure shows the co-authorship network connecting the top 25 collaborators of Mengxing Liu. A scholar is included among the top collaborators of Mengxing Liu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mengxing Liu. Mengxing Liu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

1.

Chen, Lu, Ying Liang, Hongyan Wei, et al.. (2025). NamiRNA‐Enhancer Network: The Changing Era Challenge and Chance of miRNA. Advanced Science. 12(39). e06830–e06830.

2.

Chen, Lu, Wenxuan Li, Qunyan Yao, et al.. (2025). HBV sequence integrated to enhancer acting as oncogenic driver epigenetically promotes hepatocellular carcinoma development. Journal of Experimental & Clinical Cancer Research. 44(1). 155–155. 1 indexed citations

3.

Liu, Mengxing, et al.. (2024). Wind Speed Correction Method for Wind Power Based on Markov Chains. 441–446.

4.

Liu, Mengxing, et al.. (2024). One-pot accessing of meso‑aryl heptamethine indocyanine NIR fluorophores and potential application in developing dye-antibody conjugate for imaging tumor. Chinese Chemical Letters. 36(4). 109994–109994. 1 indexed citations

5.

Li, Wenxuan, et al.. (2024). Highly homologous miR-135a and miR-135b converting non-small cell lung cancer from suppression to progression via enhancer switching. Human Molecular Genetics. 33(15). 1356–1366. 3 indexed citations

6.

Liu, Mengxing, et al.. (2024). Evaluate the value of prolonging the duration of tiopronin for injection administration in preventing hepatotoxicity. Scientific Reports. 14(1). 3674–3674. 2 indexed citations

7.

Zhang, Hong‐Xing, et al.. (2024). Excited-State Conjugation/De-Conjugation Driven Nonradiative Thermal Deactivation for Developing Fluorogenic Probes to Diagnose Cancers. SHILAP Revista de lepidopterología. 2(6). 432–441. 4 indexed citations

8.

Liang, Ying, Dapeng Zhang, Lina Peng, et al.. (2024). miR‐1246 promotes osteosarcoma cell migration via NamiRNA‐enhancer network dependent on Argonaute 2. SHILAP Revista de lepidopterología. 5(4). e543–e543. 1 indexed citations

9.

Yang, Kai, Hongchun Sun, Mengxing Liu, et al.. (2023). Morphological and Physiological Mechanisms of Melatonin on Delaying Drought-Induced Leaf Senescence in Cotton. International Journal of Molecular Sciences. 24(8). 7269–7269. 16 indexed citations

10.

Luo, Bo, Jing Zhang, Wei Li, et al.. (2023). Design, Synthesis, and Antifungal Activities of Novel Pyrazole-4-carboxamide Derivatives Containing an Ether Group as Potential Succinate Dehydrogenase Inhibitors. Journal of Agricultural and Food Chemistry. 71(24). 9255–9265. 35 indexed citations

11.

Liang, Ying, Lu Qi, Wei Li, et al.. (2021). Reactivation of tumour suppressor in breast cancer by enhancer switching through NamiRNA network. Nucleic Acids Research. 49(15). 8556–8572. 42 indexed citations

12.

Xu, Meng, et al.. (2021). [A Survey of Patient Monitoring Alarms in Cardiac Care Units].. PubMed. 45(4). 450–453. 1 indexed citations

13.

Li, Yijing, et al.. (2021). Prediction of cardiac arrest in critically ill patients based on bedside vital signs monitoring. Computer Methods and Programs in Biomedicine. 214. 106568–106568. 20 indexed citations

14.

Liu, Mengxing, et al.. (2021). 渤中19-6潜山构造带凝析油中轻烃地球化学特征及意义. Earth Science-Journal of China University of Geosciences. 46(10). 3645–3645. 3 indexed citations

15.

Liu, Jing, Mengxing Liu, Hong‐Xing Zhang, & Wei Guo. (2021). High‐Contrast Fluorescence Diagnosis of Cancer Cells/Tissues Based on β‐Lapachone‐Triggered ROS Amplification Specific in Cancer Cells. Angewandte Chemie International Edition. 60(23). 12992–12998. 61 indexed citations

16.

Liu, Jing, Mengxing Liu, Hong‐Xing Zhang, & Wei Guo. (2021). High‐Contrast Fluorescence Diagnosis of Cancer Cells/Tissues Based on β‐Lapachone‐Triggered ROS Amplification Specific in Cancer Cells. Angewandte Chemie. 133(23). 13102–13108. 11 indexed citations

17.

Zhang, Hong‐Xing, Jing Liu, Yuanqiang Sun, Mengxing Liu, & Wei Guo. (2020). Carbon–Dipyrromethenes: Bright Cationic Fluorescent Dyes and Potential Application in Revealing Cellular Trafficking of Mitochondrial Glutathione Conjugates. Journal of the American Chemical Society. 142(40). 17069–17078. 56 indexed citations

18.

Liu, Jing, Mengxing Liu, Hong‐Xing Zhang, et al.. (2019). Exploring cysteine regulation in cancer cell survival with a highly specific “Lock and Key” fluorescent probe for cysteine. Chemical Science. 10(43). 10065–10071. 84 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact